It was never known that endothelial tip cells have such unique secretion or deposition profiles, let alone shown that these profiles actually favor tumor growth.»
«The idea is that every patient will receive a unique cocktail of neoepitope - derived peptides, based on the genetic profile of a tumor, to generate a highly immunogenic and clinically relevant response,» he says.